tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Financial Statements

113 Followers

Sinovac Biotech Financial Overview

Sinovac Biotech's market cap is currently ―. The company's EPS TTM is $-1.081; its P/E ratio is -5.98; Sinovac Biotech is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.22B$ 11.32B$ 11.85B$ 13.42B$ 9.82B
Total Assets$ 13.66B$ 14.11B$ 15.07B$ 16.75B$ 12.63B
Total Debt$ 298.98M$ 70.31M$ 81.72M$ 144.91M$ 174.58M
Net Debt$ -10.92B$ -11.25B$ -11.76B$ -13.27B$ -9.64B
Total Liabilities$ 1.64B$ 1.40B$ 971.93M$ 2.87B$ 3.50B
Stockholders Equity$ 8.71B$ 8.92B$ 9.47B$ 9.33B$ 5.87B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Sinovac Biotech Earnings and Revenue History

Sinovac Biotech Debt to Assets

Sinovac Biotech Cash Flow

Sinovac Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis